University of California San Francisco
Give to UCSFThere is a big, global problem: viruses such as HIV and COVID-19 mutate, but treatments for them don’t.
This will be one of the first and largest studies to examine the impact of factors like age and stress on vaccination effectiveness.
Further studies may reveal different patterns, including the possibility that evidence of abuse may not be apparent for months to follow, or failure by clinicians to identify abuse.
New results from an ongoing collaborative effort to slow the spread of COVID-19 shows that the prevalence of a coronavirus lineage, characterized by the L452R substitution and two other mutations in the virus’s spike protein, has significantly increased in recent months.
Susan Acton discovered ACE2 while searching for new cardiovascular drugs. Decades later, she was surprised to see it popping up in the news once COVID took hold.
A new study finds that inherited genetic variation plays a role in who is likely to benefit from checkpoint inhibitors, which release the immune system’s brakes so it can attack cancer.
A UCSF team has engineered a tiny antibody capable of neutralizing the coronavirus.
Patients with severe COVID-19 produce antibodies that paradoxically shut down their immune system’s virus-fighting response just when they need it most.
Few would have predicted last January that a pandemic would upend our daily lives. But one grueling year in, UCSF experts have a clearer view of the path ahead.
“It’s too soon to know if this variant will spread more rapidly than others," said Erica Pan, MD, MPH, State Epidemiologist for the California Department of Public Health.
Scientists at UCSF have developed ReScan, an innovative new serological test that employs a specialized version of the technique known as phage display.
A mutated version of the novel coronavirus has been making the news for being more contagious. We asked UCSF infectious disease expert Charles Chiu, MD, PhD, how the new variant emerged, whether available vaccines will still work, and what we need to do now.
A UCSF pediatrician who is researching methods to control the spread of coronavirus shares why she’s optimistic that schools can reopen safely.
The device, which may be a better illness indicator than a thermometer, could lead to earlier isolation and testing, curbing the spread of infectious diseases.
Though ticks are notorious for transmitting pathogens such as the Lyme disease bacterium, how does their immune system keep them safe from contracting pathogens themselves?
We asked several UCSF experts for a personal take on what will convince them that a vaccine is safe.
This type of test could be used as a check against possible errors generated by the standard tests that directly detect the SARS-CoV-2 virus, the scientists said.
Immunotherapies are a promising anticancer arsenal and work by mobilizing the immune system to recognize and destroy cancer cells. Currently, however, only a third of patients respond to
Finding medicines that can kill cancer cells while leaving normal tissue unscathed is a Holy Grail of oncology research.
An international research team led by UCSF scientists has shown, for the first time, that gut immune cells travel to the brain during multiple sclerosis flare-ups in patients.
Cardiologist Nisha Parikh, MD, MPH, discusses what we know so far about COVID-19’s impact on the body’s cardiovascular system, from affecting the heart’s rhythm to impairing its ability to pump blood throughout the body.
More than a dozen U.S. Immigration and Customs Enforcement (ICE) detention centers experienced large, repeated outbreaks of vaccine-preventable illnesses in the last three years, according to a new study by researchers at UCSF.
Now in their seventh year, the Best Global Universities rankings focus on schools’ academic research and reputation overall instead of specific undergraduate and graduate programs. These global rankings help the increasing number of students exploring international higher education options to more accurately compare institutions around the world.